News & Publications
- Chambers Global, 14.2.19
- Benchmark Canada®, 31.1.19
Rita Andreone, QC and Chat Ortved prepared a Q&A guide to "Corporate Governance and Directors' Duties in Canada: Overview." The Q&A gives a high level overview of board composition, the comply or explain approach, management rules and authority, directors’ duties and liabilities, transactions with directors and conflicts, company meetings, internal controls, accounts and audit, institutional investors and reform proposals.
Craig Ferris, QC, FCIArb. was quoted in a recent article in The Lawyer's Daily, "B.C. modernizes class action legislation; group looking into same for Ontario." This article discusses British Columbia's changes to modernize its legislation on class action proceedings and examines how this may lead to an increase in class actions.
Read the full article here.
On Thursday, April 12, 2018, Arbutus Biopharma Corporation (“Arbutus”), an industry-leading hepatitis B virus (HBV) therapeutic solutions company and Roivant Sciences Ltd. (“Roivant”) announced that they have entered into an agreement to launch Genevant Sciences (“Genevant”), a jointly-owned company focused on the discovery, development, and commercialization of a broad range of RNA-based therapeutics.